ArticleBMC cancer2019

Tumor Hypervascularity and hand-foot-skin reaction predict better outcomes in combination treatment of TACE and Sorafenib for intermediate hepatocellular carcinoma.

Enxin Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.